VVP
CLGN icon

Venture Visionary Partners’s CollPlant Biotechnologies CLGN Stock Holding History

Venture Visionary Partners’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-115
Closed -$920 – 665
2022
Q2 		$920 Buy
+115
New +$1.06K ﹤0.01% 1608

Other funds holding CLGN

RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Venture Visionary Partners's CLGN Position: Q3 2022 in Review

Venture Visionary Partners sold out of CollPlant Biotechnologies (CLGN) in Q3 2022, closing a stake of 115 shares — an estimated $920 sold.

Venture Visionary Partners first reported a position in CLGN in Q2 2022 and held it in 1 quarter. The position peaked at $920 in Q2 2022. 21 funds tracked by Wall St. Rank hold CLGN as of Q3 2022.

  • Venture Visionary Partners reported no remaining CollPlant Biotechnologies position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 115 CollPlant Biotechnologies shares in Q3 2022, an estimated $920.
  • Venture Visionary Partners first reported a position in CollPlant Biotechnologies in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's CollPlant Biotechnologies position peaked at $920 in Q2 2022.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.